Researchers find that new approach to boosting protein production could advance mRNA and protein-based medicines

Medicines that are based on mRNAs and proteins—particularly vaccines and antibodies—are time-intensive and costly to make. The challenge is in producing the necessary mRNAs and proteins in large enough amounts at low cost.

Leave A Comment

Your email address will not be published. Required fields are marked *